Navigation Links
Radiation therapy combo cures prostate cancer long-term

Seventy-four percent of men treated with a combination of radiation seed implants and external beam radiation therapy for prostate cancer are cured of their disease 15 years following their treatment, according to a study released today in the International Journal of Radiation Oncology*Biology*Physics, the official journal of ASTRO.

This study was conducted by the physicians at the Seattle Prostate Institute. Doctors wanted to look at the combination of seed implants and external beam radiation therapy, two different types of radiation therapy, to prolong the long-term disease cure rates for prostate cancer. Over the course of 15 years, doctors followed 232 men with early-stage prostate cancer who received a course of external beam radiation therapy followed by permanent seed implants a few weeks later. Sixty-five percent of these patients had T2b-T3 disease and the entire group had an average pre-treatment PSA of 15 ng/ml.

Seed implants, also called brachytherapy, are small radioactive pellets, each about the size of a grain of rice. The seeds are inserted into the prostate through small needles during a brief outpatient procedure. External beam radiation therapy involves a series of 25 short daily outpatient treatments, where a radiation oncologist precisely directs high energy radiation beams to kill cancer cells.

"This study is exciting because it shows that the combination of brachytherapy and external beam therapy are successful long-term at curing men of their prostate cancer," said John E. Sylvester, M.D., lead author of the study and the Director of the Seattle Prostate Institute in Seattle. "This is good news for men with prostate cancer since radiation therapy is less invasive, spares healthy tissue and helps patients return to regular activities sooner than surgery."
'"/>

Source:American Society for Therapeutic Radiology and Oncology


Page: 1

Related biology news :

1. Adding Radiation Therapy To Chemotherapy Improves Survival In Patients With High-risk Breast Cancer
2. Duke Experiments Boost Radiations Cancer-Killing Effects
3. Radiation-killed bacteria vaccine induces broad immune response in mice
4. Radiation-armed robot rapidly destroys human lung tumors
5. Radiation after surgery doubles survival time for some lung cancer patients
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Combination therapy boosts effectiveness of telomere-directed cancer cell death
8. Gene therapy converts dead bone graft to new, living tissue
9. Study identifies predictors of HIV drug resistance in patients beginning triple therapy
10. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
11. Muscle-targeted gene therapy reverses rare muscular dystrophy in mice

Post Your Comments:
(Date:11/30/2009)... , A team of scientists from The Forsyth Institut...e CDC and the Wadsworth Center, have used state-of...hitecture of Treponema pallidum, the bacterium whi...d structure of the bacteria can now be shown in th... of the pathogen and reveals previously unknown fe...
(Date:11/30/2009)... , The Editors of The Journal of Experimental Bi...in from Centre National de la Recherche Scientifiq...s is the winner of this year,s JEB Outstanding P...f an outstanding achievement and is intended to en...e JEB Editor-in-Chief, and adds that ,we truly a...
(Date:11/30/2009)... , A major obstacle to HIV research is the virus,...ning that scientists, traditional tools, like the ...tion. Now, a team of researchers writing in BioMed...ade an ingenious assault on this problem by creati...without being infected with HIV. , George Kassio...
Breaking Biology News(10 mins):Scientists gain new understanding of disease-causing bacteria 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 2French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 3French scientist wins the Journal of Experimental Biology Outstanding Paper Prize 2009 4A reductionist approach to HIV research 2Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 1Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 2Lack of Insurance to Blame for Almost 45 000 Deaths 3A Study 57560 3Rare genetic disease successfully reversed using stem cell transplantation 9972 1Rare genetic disease successfully reversed using stem cell transplantation 9972 2Rare genetic disease successfully reversed using stem cell transplantation 9972 3Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 1Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 2Micromet to Host Conference Call and Webcast to Discuss MT110 Data Presented at ECCO ESMO on September 22 2009 14130 3
...scovered female pelvis is changing minds about the...tus, and consequently revising notions about how s...not far from the site that yielded the 3.2 million...arensi "Lucy," the pelvis indicates that Homo erec... ago, had a larger birth canal than originally sus...
... how life started remains a major challenge for sc...COST ,Frontiers of Science, conference in Sicily i... to the problem. The first applies complex systems... The second involves studying Mars, which may yiel...fe evolved. , Gnter Von Kiedrowski, of Ruhr Unive...
...pe to gain a greater understanding of disease and ...l map the expression of genes that control develop...stitute at the University of Edinburgh, in collabo...), University College London, University of Bath a...hree dimensional images of chicks taken during the...
Other Biology News:Complex systems and Mars missions help understand how life began 2Complex systems and Mars missions help understand how life began 3Chicks to give scientists clearer picture of fetal development 2
(Date:12/1/2009)... , SARASOTA, Fla., Dec. 1 ...s, Osprey Biotechnics Inc. of Sarasota has appoint...tributor. ,, Lake is located near Birmingham, ...ial bacteria which serve the agricultural, waste w...bred to be hungry and to open drain fields, and cl...
(Date:12/1/2009)... EpiVax, Inc. today announce...IX: RO, ROG; OTCQX: RHHBY) aimed at evaluating Epi...h could potentially reduce detrimental immune resp...-EpiVax collaboration, the EpiVax Tregitope techno...nogenicity of protein therapeutics. , ...
(Date:12/1/2009)... , HUNTINGTON BEACH, California and...world leader in molecular cancer diagnostics, anno... Medicare administrator, has established,coding gu...rint is Agendia,s,FDA-cleared breast cancer recurr...ce 2008. , Patients across the United Sta...
(Date:12/1/2009)... , NEW YORK and MONTREAL, Dec. 1 /PRNewswire-...rtner -ICBS Ltd. (OTCPK: ICBT), announced today th...; Manufacturing Inc., of Canada for the manufactur...istribution in the U.S. ,, "We have seen the di...n fresh vegetables and packaged salads in the past...
Breaking Biology Technology:EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 2EpiVax, Inc. forms Collaborative Research Agreement with Roche to Develop Tregitope Technology 3Medicare Administrator Establishes Reimbursement Coding Policy for Agendia's Breast Cancer Recurrence Test MammaPrint(R) 2
...Net Revenues Up 98% and Adjusted EBITDA Up 70% Yea...ewswire/ -- WuXi PharmaTech,(Cayman) Inc. (NYSE: ...medical device research and development outsourcin...States, today announced its unaudited financial,re...08. During the quarter,WuXi,s net revenue increase...
...er Revenue Increases by 45% From Prior Year ...0 - Six Month Revenue Increases by 37% Fr... Income of $786,000, SAN DIEGO, Nov. 12 Imagenet...y results for its second fiscal quarter,and six mo...r the quarter,were $2,656,000 an increase of 45% f...
...eden, November 12 Cellectricon, a leading,provide...ry, has today,received its most significant and la...ee Cellaxess(R)HT systems and the customer is a le...de proves the system,s unique features and,value, ...te-of-the-art,products for drug discovery and rese...
Other Biology Technology:WuXi PharmaTech Announces Third Quarter 2008 Results 2WuXi PharmaTech Announces Third Quarter 2008 Results 3WuXi PharmaTech Announces Third Quarter 2008 Results 4WuXi PharmaTech Announces Third Quarter 2008 Results 5WuXi PharmaTech Announces Third Quarter 2008 Results 6WuXi PharmaTech Announces Third Quarter 2008 Results 7WuXi PharmaTech Announces Third Quarter 2008 Results 8WuXi PharmaTech Announces Third Quarter 2008 Results 9WuXi PharmaTech Announces Third Quarter 2008 Results 10WuXi PharmaTech Announces Third Quarter 2008 Results 11WuXi PharmaTech Announces Third Quarter 2008 Results 12WuXi PharmaTech Announces Third Quarter 2008 Results 13Imagenetix, Inc. Reports Second Quarter and Six Month Results 2Imagenetix, Inc. Reports Second Quarter and Six Month Results 3Imagenetix, Inc. Reports Second Quarter and Six Month Results 4Cellectricon Receives Milestone Order for Cellaxess(R)HT, the World's First High Throughput RNAi Screening System 2
... The new ArraySlide 96 chamber fits one microarray...faces for multiple simultaneous protein, gene expr...r systems, this device utilizes a compression fit ...adhesives. The chamber itself is made from a durab...
...lexing platform that uses advanced microarray tech...ence detection and pharmacogenetics applications. ...ied to an open and flexible electronic microarray,... all tests sites have been utilized. This open sys...
Rat siTrio from B-Bridge International
Phage Display cDNA Library Screening Kit from Spring Bioscience
Biology Products: